Drs. Miranda and Pastore take positions in Bay Area Biotech.

Diego Miranda, PhD followed his passion in hepatic biology and joined Gilead in 2018 to identify drug/therapies that might mitigate NAFLD or fatty liver disease. Mayra Pastore, PhD left the lab in 2019 and is now living her dream as an MSL (Medical Science Liaison) in the Bay Area working with BMS.